APA (7th ed.) Citation

JA, W., CR, G., BB, B., VH, G., BD, S., & G, B. (2018). A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD. Ophthalmic surgery, lasers & imaging retina, 49(5), 336. https://doi.org/10.3928/23258160-20180501-07

Chicago Style (17th ed.) Citation

JA, Wells, Gonzales CR, Berger BB, Gonzalez VH, Sippy BD, and Burian G. "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD." Ophthalmic Surgery, Lasers & Imaging Retina 49, no. 5 (2018): 336. https://doi.org/10.3928/23258160-20180501-07.

MLA (9th ed.) Citation

JA, Wells, et al. "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD." Ophthalmic Surgery, Lasers & Imaging Retina, vol. 49, no. 5, 2018, p. 336, https://doi.org/10.3928/23258160-20180501-07.